Boehringer Ingelheim Competitors and Similar CompaniesClear all

Boehringer Ingelheim's competitors and similar companies include Pfizer.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date
Founding Date
1958
Founding Date
1849
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Ingelheim am Rhein, DE HQ
Ouled Fayet, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Minsk, BY
Bruxelles, BE
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Footscray, AU
Mulgrave, AU
Sydney, AU
Wien, AT
see more
Employees
Employees
1,2338% increase
Employees
81,0008% decrease

Financial

Revenue (est.)
Revenue (est.)
€12.7b (FY, 2023)
Revenue (est.)
$62.6b (FY, 2025)
Cost of goods
Cost of goods
€4b (FY, 2023)
Cost of goods
$16.1b (FY, 2025)
Gross profit
Gross profit
€8.7b (FY, 2023)
Gross profit
$46.5b (FY, 2025)
Net income
Net income
€5.8b (FY, 2023)
Net income
$7.8b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company